Cronin-Fenton DP - Search Results

1

Opioids and breast cancer recurrence: A Danish population-based cohort study.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen PM, Ejlertsen B, Sjøgren P, Kehlet H, Sørensen HT. Cronin-Fenton DP, et al. Cancer. 2015 Oct 1;121(19):3507-14. doi: 10.1002/cncr.29532. Epub 2015 Jul 24. Cancer. 2015. PMID: 26207518 Free PMC article.

2

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005.

Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sørensen HT. Cronin-Fenton DP, et al. Br J Cancer. 2007 May 7;96(9):1462-8. doi: 10.1038/sj.bjc.6603717. Epub 2007 Apr 3. Br J Cancer. 2007. PMID: 17406360 Free PMC article.

3

Trends in breast-conserving surgery in Denmark, 1982-2002.

Ahern TP, Larsson H, Garne JP, Cronin-Fenton DP, Sørensen HT, Lash TL. Ahern TP, et al. Eur J Epidemiol. 2008;23(2):109-14. doi: 10.1007/s10654-007-9207-1. Epub 2007 Nov 7. Eur J Epidemiol. 2008. PMID: 17987392

4

Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study.

Søgaard KK, Cronin-Fenton DP, Pedersen L, Sørensen HT, Lash TL. Søgaard KK, et al. Inflamm Bowel Dis. 2008 Apr;14(4):519-25. doi: 10.1002/ibd.20341. Inflamm Bowel Dis. 2008. PMID: 18069672

5

Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.

Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH. Friis S, et al. Eur J Cancer Prev. 2008 Apr;17(2):88-96. doi: 10.1097/CEJ.0b013e3282b6fd55. Eur J Cancer Prev. 2008. PMID: 18287865

6

Modification of tamoxifen response: what have we learned?

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Kvistgaard ME, Rosenberg CL, Silliman RA, Sørensen HT. Lash TL, et al. J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432. J Clin Oncol. 2008. PMID: 18375910 No abstract available.

7

Inequity in colorectal cancer treatment and outcomes: a population-based study.

Carsin AE, Sharp L, Cronin-Fenton DP, Céilleachair AO, Comber H. Carsin AE, et al. Br J Cancer. 2008 Jul 22;99(2):266-74. doi: 10.1038/sj.bjc.6604467. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594530 Free PMC article.

8

Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Sørensen HT. Lash TL, et al. Cancer Sci. 2008 Aug;99(8):1706-7. doi: 10.1111/j.1349-7006.2008.00864.x. Cancer Sci. 2008. PMID: 18754887 Free PMC article. No abstract available.

9

No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications.

Ahern TP, Pedersen L, Cronin-Fenton DP, Sørensen HT, Lash TL. Ahern TP, et al. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2562-4. doi: 10.1158/1055-9965.EPI-09-0516. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690182 Free PMC article.

10

Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark.

Chang ET, Cronin-Fenton DP, Friis S, Hjalgrim H, Sørensen HT, Pedersen L. Chang ET, et al. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):59-64. doi: 10.1158/1055-9965.EPI-09-0909. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20056623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page